Oculis
Clinical trials sponsored by Oculis, explained in plain language.
-
New eye drug tested for nerve inflammation safety
Disease control CompletedThis study tested the safety of an experimental drug called OCS-05 in people with a sudden episode of optic neuritis, which is inflammation of the eye's nerve. Thirty-six participants received either OCS-05 or a placebo (inactive substance) for five days, in addition to the stand…
Phase: PHASE2 • Sponsor: Oculis • Aim: Disease control
Last updated Apr 04, 2026 05:05 UTC
-
New eye drop tested to ease recovery from common eye surgery
Symptom relief CompletedThis study tested whether a new eye drop called OCS-01 could reduce pain and inflammation after cataract surgery. Researchers compared two different dosing schedules (once or twice daily) against a placebo drop in 153 patients. The goal was to find the best way to help patients r…
Phase: PHASE2 • Sponsor: Oculis • Aim: Symptom relief
Last updated Mar 30, 2026 14:30 UTC